Kusajili – Centralise les essais cliniques mondiaux

Résultat de votre recherche par promoteur : Wyeth Pharmaceuticals Inc. - Global Medical Affairs

Homme Max 99 ans
Wyeth Pharmaceuticals Inc. - Global Medical Affairs MAJ Il y a 4 ans

A Multicenter, Open-Label Study to Compare On-Demand Treatment With 2 Prophylaxis Regimens of Recombinant Coagulation Factor IX (BeneFIX) Reformulated Drug Product (rFIX-R) in subjects with Severe Hemophilia B To evaluate the efficacy and safety of BeneFIX infused as prophylaxis regimens, compared with BeneFIX administered in an on-demand regimen only.

Pays Aucun
Organes Aucun
Spécialités Aucune

Essai clos aux inclusions

Plus d'informations